Jayme Mendal, CEO and President of EverQuote, Inc. (NASDAQ:EVER), filed a Form 4 on November 4, 2026, disclosing option exercises and open-market sales of Class A Common Stock on November 2 and November 4, 2026.
Key Highlights
- November 2 option exercise: Mendal exercised stock options covering 11,406 shares at an exercise price of $6.96, acquiring them at $0 cost under a Rule 10b5-1 trading plan adopted June 16, 2026.
- November 2 sales: Mendal sold 18,157 shares at a weighted average price of $23.82 (range $23.22 to $24.21) and 2,824 shares at a weighted average price of $24.27 (range $24.22 to $24.32), both under the same 10b5-1 plan.
- November 4 option exercise: Mendal exercised options covering 28,725 shares at $6.96, paying the exercise price in cash outside of a Rule 10b5-1 plan; according to the filing, no shares were sold or withheld in connection with this exercise.
- Resulting ownership: Following all reported transactions, Mendal directly held 576,978 shares of Class A Common Stock.
- Remaining options: After both exercises, Mendal held 62,938 stock options with an exercise price of $6.96 and an expiration date of October 17, 2027.
- Option origin: According to the filing, the exercised options were granted on October 18, 2017, with 25% vesting on September 30, 2018, and the remainder vesting monthly over the following three years.
Details of Mendal's November 2026 Transactions at EverQuote
According to the Form 4 filed with the SEC, Jayme Mendal, who serves as CEO and President of EverQuote, Inc. (NASDAQ:EVER), reported a series of transactions in Class A Common Stock on November 2 and November 4, 2026. On November 2, Mendal exercised stock options for 11,406 shares at an exercise price of $6.96 per share, acquiring them for $0 net cost as part of a Rule 10b5-1 trading plan. That same day, Mendal sold a total of 20,981 shares in two tranches: 18,157 shares at a weighted average price of $23.82, and 2,824 shares at a weighted average price of $24.27. The filing notes that the first tranche traded in a range of $23.22 to $24.21 and the second in a range of $24.22 to $24.32, with both sales effected under the 10b5-1 plan adopted on June 16, 2026.
On November 4, 2026, Mendal exercised an additional 28,725 options at $6.96 per share. The filing states this exercise was made outside of the Rule 10b5-1 trading plan, with the exercise price paid in cash. The filing also states that "the reporting person continues to hold all shares acquired upon exercise, and no shares were sold or withheld in connection with this exercise." Following this transaction, Mendal's direct beneficial ownership stood at 576,978 shares of Class A Common Stock, and 62,938 stock options remained outstanding under the original October 2017 grant, expiring October 17, 2027.
The Form 4 was signed by Jon Ayotte as attorney-in-fact for Jayme Mendal and filed on November 4, 2026. The filing carries the Rule 10b5-1(c) checkbox, indicating that the November 2 transactions were made pursuant to a pre-established written plan intended to satisfy that rule's affirmative defense conditions.
What Was Disclosed
Jayme Mendal, CEO and President of EverQuote, Inc., disclosed option exercises totaling 40,131 shares and open-market sales of 20,981 shares of Class A Common Stock on November 2-4, 2026, resulting in direct ownership of 576,978 shares.



Please wait processing your request...